Science Center Ventures

Science Center Ventures, based in Philadelphia, specializes in investing in life sciences and technology companies. It is part of Science Center, a hub for entrepreneurial activity and healthcare innovation.

Heath Naquin

Vice President Government and Capital Engagement

14 past transactions

Taurus Vascular

Non Equity Assistance in 2023
Taurus Vascular is a medical device company dedicated to enhancing long-term outcomes for patients suffering from aortic aneurysms. The company is focused on transforming the standard of care by developing innovative medical device technology aimed at addressing the complications associated with endoleaks. This technology is designed to facilitate accelerated shrinkage of the aneurysm sac following endovascular aortic aneurysm repair (EVAR). By improving the effectiveness of treatment, Taurus Vascular aims to significantly enhance patient outcomes in the healthcare sector.

AB Fertitlity

Pre Seed Round in 2023
AB Fertitlity develops products for reproductive medicine.

EmpiricaLab

Pre Seed Round in 2023
EmpiricaLab develops an online learning platform tailored for healthcare teams. It facilitates peer learning through collaborative authoring, sharing of work-relevant content, and a work-integrated learning curriculum.

MTDS Solution

Pre Seed Round in 2023
MTDS Solution is a company focused on enhancing health and wellness through innovative service offerings. It provides resources aimed at reducing the operational burden on medical institutions while also serving the broader community. The company has developed fully automated kiosks for polymerase chain reaction (PCR) testing, which streamline the testing process for various health concerns. These kiosks enable patients to conduct a wide range of tests, including those for influenza, sexually transmitted infections, blood-borne pathogens, genetic conditions, and drug use. The integration of these kiosks with a user-friendly mobile application further supports patients in managing their health effectively and conveniently.

Steradian Technologies

Seed Round in 2023
Steradian Technologies develops a noninvasive, portable diagnostic platform that detects infectious diseases from breath within seconds. Using photon-based detection and focal point projection, the system analyzes exhaled air to identify bacteria, viruses, and biomarkers without laboratory processing or extensive sample preparation. The technology aims to provide rapid, accurate, point-of-care results, enabling clinicians to diagnose infections quickly and guide treatment without the need for traditional lab workflows.

Prana Thoracic

Non Equity Assistance in 2023
Prana Thoracic is a Houston-based medical device company developing tools to enable early diagnosis and minimally invasive treatment of lung cancer. Founded by surgeons, engineers, and entrepreneurs, the company aims to improve outcomes by making it easier to manage suspicious lung nodules and obtain definitive tissue for diagnosis, using tissue-sparing surgical instruments capable of capturing nodules and sealing tissue during minimally invasive procedures.

BioCurie

Pre Seed Round in 2023
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.

Trace Orthopedics

Seed Round in 2023
Trace Orthopedics specializes in the development of innovative medical devices for tendon reattachment without the need for traditional surgery. The company has created a minimally invasive procedure that utilizes a specialized device designed to repair partially torn tendons by inserting a needle through the skin. This technique allows for the secure attachment of tendons back to bone, eliminating the need for general anesthesia or an operating room visit. As a result, patients benefit from quicker recovery times and reduced healthcare costs. Trace Orthopedics aims to enhance patient outcomes and streamline the treatment process in orthopedic care.

Rubitection

Seed Round in 2023
Rubitection is a medical technology company that develops AI-powered skin health monitoring and care-management solutions for wound care, dermatology, and cosmetic applications. The company offers a handheld system and related assessment tools designed to detect early signs of skin breakdown, including bedsores, diabetic foot ulcers, and other chronic dermatological conditions, enabling caregivers, physicians, and nurses to monitor risk and intervene early. Its platform provides data-driven insights to support assessment, prevention, and treatment of chronic wounds such as diabetic foot ulcers, vascular leg ulcers, psoriasis, and eczema, with the aim of improving patient outcomes and reducing care costs. Rubitection positions itself as a global standard system for skin health monitoring and care management, and is based in Pittsburgh, Pennsylvania.

Aware.ai

Pre Seed Round in 2023
Aware.ai uses AI to create virtual support communities for women and connect them to resources during pregnancy.

Opal HTM

Seed Round in 2022
Opal HTM enhances hospital safety and efficiency by employing innovative technologies to revolutionize medical equipment management and maintenance.

Gray Oncology Solutions

Pre Seed Round in 2021
Gray Oncology Solutions aims to optimize cancer treatment workflows by developing software that personalizes each patient's journey, statistically improves clinical outcomes, reduces wait-times, increases throughput, and enhances overall patient care.

Allevi

Venture Round in 2018
Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

StageMark

Series B in 2007
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.